Conditions that enable human hematopoietic stem cell engraftment in all NOD-SCID mice

Transplantation

Volumn 69, Issue 5, 2000, Pages 927-935

  Rice, Alison M ^a,c   Wood, Julie A ^a   Milross, Christopher G ^b   Collins, Cathryn J ^b   McCarthy, Nigel F ^a   Vowels, Marcus R ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IRRADIATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; SCID MOUSE; UMBILICAL CORD BLOOD;

EID: 0034654597     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200003150-00044     Document Type: Article

References (38)

1. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord blood transplantation from related and unrelated donors. N Engl J Med 1997; 337: 373.
2. Broxmeyer HE, Hangoc G, Cooper S, et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 1992; 89: 4109.
3. Purdy MH, Hogan CJ, Hami L, et al. Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation. J Hematother 1995; 4: 515.
4. Zimmerman TM, Bender JG, Lee WJ, et al. Large scale selection of CD34† peripheral blood progenitors and expansion of neutrophil precursors for clinical applications. J Hematother 1996; 5: 247.
5. + cells: committed precursor expansion does not effect immature hematopoietic progenitors. J Hematother 1997; 6: 151.
6. Emerson SG. Ex vivo expansion of hematopoietic precursors, progenitors and stem cells: the next generation of cellular therapeutics. Blood 1996; 87: 3082.
7. Piacibello W, Sanavio S, Garetto L, et al. Extensive amplification and self renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997; 89: 2644.
8. Rice A, Ripoche J, Reiffers J. Hematopoietic stem cell expansion. Transfusion Sci 1997 18: 263.
9. Bertolini F, Battaglia M, Pedrazzoli P, et al. Megakaryocyte progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 1997; 89: 2679.
10. Wermann K, Fruehauf S, Haas R, Zeller WJ. Human-mouse xenografts in stem cell research. J Hematother 1996; 5: 379.
11. Andreiole G, Mule J, Hansen C, Linehan W, Rosenberg S. Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on analysis of congenitally immunodeficient mice. J Immunol 1985; 135: 2911.
12. Nolta JA, Hanley MB, Kohn DB. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood 1994; 83: 3041.
13. Bosma M, Carroll M. The SCID mouse mutant: definitions, characterization and potential uses. Annu Rev Immunol 1991; 9: 323.
14. Dick J, Lapidot T, Pfluimio F. Transplantation of normal and leukemic human bone marrow into immune-deficient mice: development of animal models for human hematopoiesis. Immunol Rev 1991; 124: 25.
15. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241: 1632
16. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem cell population. Proc Natl Acad Sci USA 1992; 89: 2804.
17. Leigh BR, Webb S, Hancock SL, Knox SJ. Stem cell factor enhances the survival of irradiated human bone marrow maintained in SCID mice. Stem Cells 1994; 12: 430.
18. DiGiusto DL, Lee R, Moon J, et al. Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo. Blood 1996 87: 1261.
19. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunological function in NOD/LtSz-scid mice. J Immunol 1995; 154: 180.
20. Greiner DL, Shultz LD, Yates J, et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol 1995; 146: 888
21. Larochelle A, Vormoor J, Lapidot T, et al. Engraftment of immune-deficient mice with primitive hematopoietic cells from β-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Human Mol Genet 1995; 4: 163.
22. Vormoor J, Lapidot T, Pflumio F, et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994; 83: 2489.
23. Lapidot T, Fajerman Y, Kollet O. Immune-deficient SCID and NOD-SCID mice models as functional assays for studying normal and malignant human haematopoiesis. J Mol Med 1997; 75: 664.
24. Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD-SCID mouse bone marrow: implications for gene therapy. Nat Medicine 1996; 2: 1329.
25. Wang JCY, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilised peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997; 89: 3919.
26. + cells. Blood 1998; 91: 630.
27. Kamel Reid S, Letarte M, Doedens M, et al. Bone marrow from children in relapse with pre-B acute lymphoblastic leukaemia proliferates and disseminates rapidly in scid mice. Blood 1991; 78: 2973.
28. Baersch G, Mollers T, Hotte A, et al. Good engraftment of B-cell precursor ALL in NOD-SCID mice. Klin Padiatr 1997; 209: 178.
29. + cells. J Hematother 1996; 5: 255.
30. McKinlay AF. Thermoluminescence dosimetry. Medical Physics Handbooks 5. Bristol: Adam Hilger Ltd., 1981.
31. Bhatia M, Wang JCY, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl Acad Sci USA 1997; 94: 5320.
32. Schwarzenberger P, Spence S, Lohrey N, et al. Gene transfer of multidrug resistance into a factor-dependent human hematopoietic progenitor cell line: In vivo model of genetically transferred chemoprotection. Blood 1996; 87: 2733.
33. Cassel A, Cottler-Fox M, Doren S, Dunbar CE. Retroviral-mediated gene transfer into CD34 enriched human peripheral blood stem cells. Exp Hematol 1993; 21: 585.
34. + progenitors to sustain long-term haematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood 1997; 89: 446.
35. Rice A, Boiron J-M, Barbot C, et al. Cytokine-driven amplification of 5-FU resistant peripheral blood stem cells (PBSC): self renewal and commitment capacity. Exp Hematol 1995; 23: 303.
36. Traycoff CM, Kosak ST, Grigsby S, Srour EF. Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 1995; 85: 2059
37. + enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 1997; 90: 85.
38. 2-microglobulin-deficient NOD-SCID mice. J Immunol 1997; 158: 3578.